Moreover, transgenic mice with cardiac-specific overexpression of JMJD2A develop exaggerated cardiac hypertrophy compared to control mice following transverse aortic constriction (TAC) whereas jmjd2a-null animals seem to be protected against TAC-induced cardiac stress (Zhang et al., 2011). This evidence concerns the gene KDM4A and cardiac hypertrophy.